SNS-201

N/A

Report date: 2024/01/04 17:19:08

Base Information

Drug NameSNS-201
Drug Alias NameSNS-201
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-V-domain Ig suppressor of T-cell activationAnti-CD28
TargetsV-domain Ig suppressor of T-cell activationT-cell-specific surface glycoprotein CD28
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSensei Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSensei Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A